Bellicum Pharma (BLCM) Misses Q2 EPS by 5c

Bellicum Pharma (NASDAQ: BLCM) reported Q2 EPS of ($0.60), $0.05 worse than the analyst estimate of ($0.55).

For earnings history and earnings-related data on Bellicum Pharma (BLCM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• SanDisk upgraded at JPMorgan after investor day; shares climb